Skin and Skin Structure Infections
📧 Sign up to get email alerts when something new happens for Skin and Skin Structure Infections.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-09-27FDA Approved: CEPHALEXIN — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Cephalexin from Aurobindo Pharma Limited.
-
FDA approval · 2024-07-22FDA Approved: MEROPENEM — Original Application (Qilu Antibiotics Pharmaceutical Co., Ltd.)
FDA approved the original application for Meropenem from Qilu Antibiotics Pharmaceutical Co., Ltd., authorizing sale of a generic Meropenem …
-
FDA approval · 2024-07-11FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium from Micro Labs Limited under ANDA217805.
-
FDA approval · 2024-06-24FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium by Sandoz Inc to support changes to the approved gener…
-
FDA approval · 2024-05-01FDA Approved: PIPERACILLIN AND TAZOBACTAM — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for Civica, Inc. for Piperacillin and Tazobactam (piperacillin/tazobactam).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-05-01FDA Approved: PIPERACILLIN AND TAZOBACTAM — Supplemental Application (Eugia US LLC)
FDA approved a supplemental ANDA for Piperacillin and Tazobactam (piperacillin sodium and tazobactam sodium) manufactured by Eugia US LLC.
-
FDA approval · 2024-04-25FDA Approved: AMOXICILLIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for amoxicillin submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2024-04-24FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2023-12-11FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Devatis, Inc.)
FDA approved an Original Application for amoxicillin and clavulanate potassium (amoxicillin/clavulanate) as a generic antibiotic formulation…
-
FDA approval · 2023-09-15FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Devatis, Inc.)
FDA approves a generic amoxicillin/clavulanate potassium product under an Original Application by Devatis, Inc.
-
FDA approval · 2023-09-13FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Devatis Inc.)
FDA approved a generic Amoxicillin and clavulanate potassium product under Original Application by Devatis Inc.
-
FDA approval · 2023-08-16FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approved Sandoz Inc's supplemental application for clarithromycin, marking a supplemental approval for this generic antibiotic. The acti…
-
FDA approval · 2022-11-02FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (USAntibiotics, LLC)
FDA approved a supplemental application for Amoxicillin and Clavulanate Potassium submitted by USAntibiotics, LLC.
-
FDA approval · 2022-02-08FDA Approved: ERTAPENEM — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for Apotex Corp to market ertapenem sodium (ERTAPENEM) as a generic antibiotic.
-
FDA approval · 2020-07-07FDA Approved: VIBATIV — Supplemental Application (Cumberland Pharmaceuticals Inc.)
FDA approved a supplemental application for VIBATIV (telavancin hydrochloride) submitted by Cumberland Pharmaceuticals Inc. The action updat…
-
FDA approval · 2020-04-22FDA Approved: LEVOFLOXACIN — Original Application (Gland Pharma Limited)
FDA approved an original application for levofloxacin from Gland Pharma Limited, authorizing a generic version of the antibiotic.
-
FDA approval · 2019-12-19FDA Approved: CEFUROXIME AXETIL — Supplemental Application (Golden State Medical Supply, Inc.)
FDA approved a supplemental application for cefuroxime axetil from Golden State Medical Supply, Inc., recognizing an update to this generic …
-
FDA approval · 2019-04-19FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the Original Application for Amoxicillin and clavulanate potassium from Aurobindo Pharma Limited, a generic antibiotic product.
-
FDA approval · 2019-03-19FDA Approved: ERTAPENEM — Original Application (Apotex Corp)
FDA approved Apotex Corp's original application for ertapenem sodium (ertapenem), a broad-spectrum carbapenem antibiotic, as a generic produ…
-
FDA approval · 2019-02-15FDA Approved: TYZAVAN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved TYZAVAN (vancomycin) from Hikma Pharmaceuticals USA Inc. under an Original Application (NDA211962). This marks the brand’s offi…
-
FDA approval · 2018-08-10FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Shandong Anxin Pharmaceutical Co., Ltd.)
FDA approved the original application for a generic Piperacillin and Tazobactam combination from Shandong Anxin Pharmaceutical Co., Ltd., ex…
-
FDA approval · 2018-06-25FDA Approved: ERTAPENEM — Original Application (Eugia US LLC)
The FDA approved an original application for ertapenem from Eugia US LLC, authorizing a generic version of the carbapenem antibiotic ertapen…
-
FDA approval · 2018-05-18FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Fresenius Kabi USA, LLC)
FDA approves Fresenius Kabi USA, LLC's original generic application for Piperacillin and tazobactam (Piperacillin and tazobactam), authorizi…
-
FDA approval · 2017-05-15FDA Approved: CEFPROZIL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Cefprozil submitted by Rising Pharma Holdings, Inc., resulting in an updated labeling for the pr…
-
FDA approval · 2015-12-07FDA Approved: AMPICILLIN AND SULBACTAM — Original Application (WG Critical Care, LLC)
FDA approved Ampicillin and Sulbactam from WG Critical Care, LLC under an Original Application (ANDA), making a generic antibiotic available…